In his role as MES business unit lead, James will use his background in software development, consultancy and technology implementation to continue to develop Zenith Technologies as a world leader in the provision of MES solutions and services to the life science industry.
This company assists pharmaceutical and medical device manufacturers with the implementation of MES solutions, providing on-the-ground support. James will be focused on forming further collaborations in the industry to support life science companies with the transition to MES and automated systems.
Commenting on the appointment, Jim Lehane, director at Zenith Technologies, said: “James has worked with us as a senior MES engineer for a number of years, supporting some of the world’s leading pharmaceutical companies with global automation projects. In his new role as MES business unit lead, James will drive Zenith Technologies forward to further success in the US and Europe, leveraging our global presence, skilled engineers and world-class implementation and support services.”
James’ appointment comes as MES technology is being adopted by the life science industry at a faster rate than any other vertical market.1 To support demand, the firm recently announced a partnership with MES software provider Werum IT Solutions.
Jim continued: “It’s an exciting time for our company, as pharmaceutical and medical device manufacturers are recognising the benefits of MES and adoption is increasing at a steady rate. In particular, we are experiencing increasing demand in the US market, which has led us to open two new offices in Oakland and San Diego.”
Based in Bluebell, PA, James will lead Zenith Technologies’ team of engineers in 16 offices globally to support clients with their manufacturing enterprise solution needs.
He said: “MES technology can dramatically improve productivity during manufacturing, however there are a number of challenges associated with its implementation. It is our goal to assist companies with the transition to MES systems so they can realise the benefits with minimal disruption to their operations.”
@ZenithIre #PAuto #Pharma #USA #MES